Fig. 2.
Fig. 2. Na-Sal regulates the expression of MCL-1. (A) Na-Sal does not effect GM-CSF–induced tyrosine phosphorylation of p42/p44 MAPK. TF-1 cells were deprived of GM-CSF for 12 hours and were either left untreated (lane 1) or stimulated with GM-CSF for 10 minutes (lanes 2 through 4). Some cells were preincubated with 5 mmol/L Na-Sal for 10 minutes (lane 3) or 60 minutes (lane 4) before being stimulated with GM-CSF. Cell lysates were analyzed with a phospho-specific MAPK antibody (New England Biolabs, Beverly, MA). (B) The expression of BCL-2, Bax, and BCL-XL is not altered by Na-Sal treatment. TF-1 cells were treated with increasing concentrations of Na-Sal (0.5, 1, 5, and 10 mmol/L) for 5 hours and the presence of BCL-2, BCL-XL, and Bax was analyzed by Western blotting. (C) Time-dependent and (D) dose-dependent inhibition of MCL-1 expression after treatment with Na-Sal. Cells were treated with 5 mmol/L Na-Sal for the indicated times (C) or were treated with the indicated concentrations of Na-Sal for 5 hours (D). The level of MCL-1 protein was determined by Western blotting. (E and F) Densitometric scanning of (C) and (D), respectively. Scanning was performed using the Ambis nonradioactive imaging system (Ambis, Inc, San Diego, CA).

Na-Sal regulates the expression of MCL-1. (A) Na-Sal does not effect GM-CSF–induced tyrosine phosphorylation of p42/p44 MAPK. TF-1 cells were deprived of GM-CSF for 12 hours and were either left untreated (lane 1) or stimulated with GM-CSF for 10 minutes (lanes 2 through 4). Some cells were preincubated with 5 mmol/L Na-Sal for 10 minutes (lane 3) or 60 minutes (lane 4) before being stimulated with GM-CSF. Cell lysates were analyzed with a phospho-specific MAPK antibody (New England Biolabs, Beverly, MA). (B) The expression of BCL-2, Bax, and BCL-XL is not altered by Na-Sal treatment. TF-1 cells were treated with increasing concentrations of Na-Sal (0.5, 1, 5, and 10 mmol/L) for 5 hours and the presence of BCL-2, BCL-XL, and Bax was analyzed by Western blotting. (C) Time-dependent and (D) dose-dependent inhibition of MCL-1 expression after treatment with Na-Sal. Cells were treated with 5 mmol/L Na-Sal for the indicated times (C) or were treated with the indicated concentrations of Na-Sal for 5 hours (D). The level of MCL-1 protein was determined by Western blotting. (E and F) Densitometric scanning of (C) and (D), respectively. Scanning was performed using the Ambis nonradioactive imaging system (Ambis, Inc, San Diego, CA).

Close Modal

or Create an Account

Close Modal
Close Modal